Targretin
What is Targretin?
Bexarotene (brand name: Targretin) is an antineoplastic (anti-cancer) agent approved by the U.S.Food and Drug Administration (FDA) (in late 1999) and the European Medicines Agency (EMA) (early 2001) for use as a treatment for cutaneous T cell lymphoma (CTCL). It is a third-generation retinoid.
Questions and answers on "Targretin"
Recent questions on Targretin
Explore "Targretin"
Related Disease & Conditions
Related Drugs/Medications